74 related articles for article (PubMed ID: 15197967)
21. Strategy for improving retransplantation in the CyA era.
Dickerman R; Langley J; Brinker K; Trevino G; Melton L; Vergne-Marini P; Wilson PK
Transplant Proc; 1993 Feb; 25(1 Pt 1):257-8. PubMed ID: 8438292
[No Abstract] [Full Text] [Related]
22. OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.
Platz KP; Mueller AR; Zytowski M; Bechstein WO; Blumhardt G; Lobeck H; Neuhaus P
Transplant Proc; 1995 Feb; 27(1):1111-3. PubMed ID: 7533357
[No Abstract] [Full Text] [Related]
23. Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation.
Griñó JM; Castelao AM; Serón D; Gonzalez C; Galceran JM; Gil-Vernet S; Andrés E; Bover J; Torras J; Alsina J
Transplant Proc; 1992 Feb; 24(1):39-41. PubMed ID: 1539329
[No Abstract] [Full Text] [Related]
24. Chronic graft-versus-host disease (GVHD) [proceedings].
Kolb HJ; Wundisch GF; Bender C; Rodt H; Thiel E; Grosse-Wilde H; Thierfelder S
Pathol Biol (Paris); 1978 Jan; 26(1):52. PubMed ID: 358092
[No Abstract] [Full Text] [Related]
25. Treatment of steroid resistant rejection following renal transplantation: benefits and risks of OKT3 therapy.
Kehinde EO; Feehally J; Scriven SD; Veitch PS; Bell PR
Transplant Proc; 1996 Jun; 28(3):1449-50. PubMed ID: 8658735
[No Abstract] [Full Text] [Related]
26. Immunosuppressive requirements for small bowel/liver transplantation.
McAlister V; Grant D; Wall W; Roy A; Ghent C; Zhong R; Duff J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1204-5. PubMed ID: 8442086
[No Abstract] [Full Text] [Related]
27. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.
Chao NJ; Schmidt GM; Niland JC; Amylon MD; Dagis AC; Long GD; Nademanee AP; Negrin RS; O'Donnell MR; Parker PM
N Engl J Med; 1993 Oct; 329(17):1225-30. PubMed ID: 8413388
[TBL] [Abstract][Full Text] [Related]
28. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Bacigalupo A; Lamparelli T; Barisione G; Bruzzi P; Guidi S; Alessandrino PE; di Bartolomeo P; Oneto R; Bruno B; Sacchi N; van Lint MT; Bosi A;
Biol Blood Marrow Transplant; 2006 May; 12(5):560-5. PubMed ID: 16635791
[TBL] [Abstract][Full Text] [Related]
29. Benefits of photopheresis in the treatment of heart transplant patients with multiple/refractory rejection.
Dall'Amico R; Montini G; Murer L; Andreetta B; Tursi V; Feltrin G; Guzzi G; Angelini A; Zacchello G; Livi U
Transplant Proc; 1997; 29(1-2):609-11. PubMed ID: 9123152
[No Abstract] [Full Text] [Related]
30. [Diagnosis and management of chronic graft-versus-host disease].
Inamoto Y
Rinsho Ketsueki; 2014 Oct; 55(10):2113-24. PubMed ID: 25297778
[No Abstract] [Full Text] [Related]
31. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease.
Gondo H; Harada M; Taniguchi S; Akashi K; Hayashi S; Teshima T; Takamatsu Y; Eto T; Nagafuji K; Yamasaki K
Bone Marrow Transplant; 1993 Nov; 12(5):437-41. PubMed ID: 8298553
[TBL] [Abstract][Full Text] [Related]
33. Plasma exchange in highly sensitized patients as induction therapy after renal transplantation.
Reisaeter AV; Fauchald P; Leivestad T; Holdaas H; Hartmann A; Pfeffer P; Sødal G
Transplant Proc; 1994 Jun; 26(3):1758. PubMed ID: 8030121
[No Abstract] [Full Text] [Related]
34. Optimization of cyclosporine monotherapy--long-term graft function.
Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
Transplant Proc; 1994 Oct; 26(5):2501-6. PubMed ID: 7940767
[No Abstract] [Full Text] [Related]
35. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression.
McAlister V; Grant D; Roy A; Yilmaz Z; Ghent C; Wall W
Transplant Proc; 1993 Feb; 25(1 Pt 2):1400-1. PubMed ID: 8442154
[No Abstract] [Full Text] [Related]
36. Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A.
Hunter AE; Bessell EM; Russell NH
Bone Marrow Transplant; 1992 Nov; 10(5):431-4. PubMed ID: 1464005
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
[TBL] [Abstract][Full Text] [Related]
38. [Control of graft-versus-host disease].
Sugita J; Teshima T
Rinsho Ketsueki; 2014 Feb; 55(2):170-6. PubMed ID: 24598183
[No Abstract] [Full Text] [Related]
39. Transfusion-associated GVHD: 10 years' experience at the American University of Beirut-Medical Center.
Aoun E; Shamseddine A; Chehal A; Obeid M; Taher A
Transfusion; 2003 Dec; 43(12):1672-6. PubMed ID: 14641862
[TBL] [Abstract][Full Text] [Related]
40. Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies.
Uberti JP; Silver SM; Adams PT; Jacobson P; Scalzo A; Ratanatharathorn V
Bone Marrow Transplant; 1997 Jun; 19(12):1233-8. PubMed ID: 9208118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
